Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
This review examines the relationship between testosterone replacement therapy (TRT) and prostate cancer risk, noting that while androgens promote prostate cancer growth in experimental models, there is no conclusive evidence linking higher testosterone levels to increased prostate cancer risk in humans. Studies have shown that TRT does not increase prostate